2013
DOI: 10.1002/pros.22693
|View full text |Cite
|
Sign up to set email alerts
|

The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B

Abstract: Pim-2 was over-expressed in PCA cell lines and tissues. It may inhibit the apoptosis of PCA cells through phosphorylating eIF4B, thus promote the tumorigenesis of PCA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
14
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 20 publications
4
14
0
Order By: Relevance
“…Overexpression of Pim1 contributes to tumorigenosis (33), and the levels of Pim proteins are associated with their actual activities. Indeed, elevated levels of Pim kinases have been associated with solid tumors and hematological malignancies (14,16). Although Pim1 but not Pim2 or Pim3 was initially identified as an NS5A interactor in our protein array assay, we also demonstrated that both Pim2 and Pim3 interacted with NS5A by coimmunoprecipitation assay.…”
Section: Discussionmentioning
confidence: 55%
“…Overexpression of Pim1 contributes to tumorigenosis (33), and the levels of Pim proteins are associated with their actual activities. Indeed, elevated levels of Pim kinases have been associated with solid tumors and hematological malignancies (14,16). Although Pim1 but not Pim2 or Pim3 was initially identified as an NS5A interactor in our protein array assay, we also demonstrated that both Pim2 and Pim3 interacted with NS5A by coimmunoprecipitation assay.…”
Section: Discussionmentioning
confidence: 55%
“…PIM-2 kinase is expressed in hematopoietic cells and functions by phosphorylating various target substrates and thus subsequently affects cell survival, cell proliferation, transcriptional activation, and protein translation. Major studies in cancer cell signaling demonstrated that PIM-2 kinase is intimately involved in the survival and proliferation of different cancer cell types, such as B cell lymphoma (5), multiple myeloma (6), and prostate cancer (7,8), suggesting that it could be a potential therapeutic target for cancer therapy. Despite a growing interest in targeting PIM-2 kinase, there is not yet a specific PIM-2 inhibitor in the clinic, possibly owing to specificity issues relating to the similar structure of PIM isoforms (9).…”
Section: Introductionmentioning
confidence: 99%
“…Among the candidates that reproducibly yielded androgen-independent tumors were mutated KRAS; RAF1, a known prostate cancer oncogene (16) that was recently described to confer metastatic potential in an in vivo model (10); ERBB2, AKT1, and constitutively active MEK1, which have been implicated in androgen independence (3); and PIM1 and PIM2, which have previously been demonstrated to be important oncogenes in prostate cancer (17, 18). In addition, we found that a wild-type form (NP_055212.2) of the Never In Mitosis A (NIMA) related kinase 6 (NEK6) scored strongly in this assay.…”
Section: Resultsmentioning
confidence: 99%